|
Dataset ID |
Tissue / Organ |
Experiment type |
Sample |
Cell type |
Marker class |
Evidence |
|
GSE175929 (5mpf) |
retina |
baseline |
5mpf, GFP-positive cells collected from two transgenic zebrafish, Tg(rho:EGFP)ja2Tg and Tg(gnat2:EGFP)ja23Tg |
Rod opsin (cluster: 11)
|
potential marker
|
NA
|
|
GSE144944 (fgfr3 +|+) |
cranial vault |
baseline |
1mpf, fgfr3 +/+ |
|
|
|
|
GSE106587 (WT) |
embryo |
baseline |
12hpf, 6 somites, wild-type TLAB embryo |
|
|
|
|
PRJNA734348 (dome, dnmt1) |
embryo |
growth |
4.3hpf, dome, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV) |
|
|
|
|
GSE168695 (5dpf) |
embryo |
baseline |
5dpf, GFP+ cells isolated from 5 dpf cldnb:lyn-EGFP embryos |
|
|
|
|
PRJNA564810 (5dpf) |
embryo |
baseline |
5dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
PRJNA564810 (1dpf) |
embryo |
baseline |
1dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
GSE158142 (12hpf) |
head |
baseline |
12hpf, 6 somites, untreatment |
|
|
|
|
GSE158142 (16hpf) |
head |
baseline |
16hpf, 14 somites, untreatment |
|
|
|
|
GSE158142 (20hpf) |
head |
baseline |
20hpf, 21-22 somites, untreatment |
|
|
|
|
GSE158142 (24hpf) |
head |
baseline |
24hpf, untreatment |
|
|
|
|
GSE150498 (wildtype, untreated) |
intestine |
baseline |
6dpf, wildtype, untreated |
|
|
|
|
GSE150498 (nod2-|-, 1X DSS) |
intestine |
disease |
6dpf, nod2-/-, 1X DSS |
|
|
|
|
GSE150498 (wildtype, 2X DSS) |
intestine |
disease |
6dpf, wildtype, 2X DSS |
|
|
|
|
GSE150498 (nod2-|-, 2X DSS+BZA) |
intestine |
disease |
6dpf, nod2-/-, 2X DSS+BZA |
|
|
|
|
PRJNA605021 (supporting cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae |
|
|
|
|
PRJNA668529 (3d) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 days |
|
|
|
|
PRJNA668529 (3h) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 hours |
|
|
|
|
GSE122680 (14dpf) |
retina |
baseline |
14dpf, WT, untreatment |
|
|
|
|
PRJNA672101 (nrl-KO) |
retina |
growth |
5mpf, three retinas from nrl-KO zebrafsih |
|
|
|
|
PRJNA551501 (2mpf) |
thyroid gland |
baseline |
2mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
GSE159709 (melanoma) |
tumor |
disease |
adult, equal numbers of sorted GFP+ (tumor) and GFP- (macroenvironment) cells |
|
|
|
|
PRJNA641144 (P_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo primary tumors |
|
|
|
|
PRJNA641144 (P_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo primary tumors |
|
|
|
|
PRJNA641144 (M_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo metastases |
|
|
|
|
PRJNA641144 (M_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo metastases |
|
|
|
|
PRJNA641144 (D_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vitro individual culture |
|
|
|
|
PRJNA641144 (D_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vitro individual culture |
|
|
|
|
PRJNA641144 (C_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vitro co-culture |
|
|
|
|
PRJNA641144 (C_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vitro co-culture |
|
|
|
|
GSE176129 (pdgfrb-positive) |
whole body |
baseline |
5dpf, FACS-isolated pdgfrb-positive cells |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
6dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
6dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
10dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
16dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
: marker.